Friday, July 10, 2026

Drug profile · INN

flortaucipir (18f)

flortaucipir (18f) (TAUVID) is a diagnostic agent.

EMA: approved PMDA: approved Various (V09) V09AX07
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — flortaucipir (18f)
Class
Various (V09)
Route
Patents
0
Programs
5
Data quality
0.83

Quick answer

flortaucipir (18f) (TAUVID) is a diagnostic agent.

Key facts

INN flortaucipir (18f)
Brand TAUVID
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09AX07

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA approved
PMDA approved

Pipeline programs

  1. C24-50 Phase 3 · George Institute for · Semantic Variant Primary Progressive Aphasia, Alcohol Use Di
  2. Treatment as Usual (TAU) Phase 3 · BRIGHT MINDS BIOSCIENCES · Drug Addiction
  3. Flortaucipir, Placebo to match LY3372689 Phase 2 · Eli Lilly and · Alzheimer Disease
  4. Standard Treatment As Usual (TAU) Phase 2 · BRIGHT MINDS BIOSCIENCES · Substance Abuse
  5. Treatment as usual (TAU) Phase 1 · BRIGHT MINDS BIOSCIENCES · Cocaine Abuse

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is flortaucipir (18f)?

flortaucipir (18f) (TAUVID) is a diagnostic agent.

What is the brand name for flortaucipir (18f)?

TAUVID is a marketed brand name for flortaucipir (18f). Check FDA Drugs@FDA for the current US label holder and prescribing information.